JYNT

+ Watchlist + Portfolio

The Joint Corp.

Recurring revenue Regulated industry Consumer brandTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $7.47
52-Week Range: $7.21 – $10.67
Market Cap: $102.96M
P/E (TTM): 52.00
EPS (TTM): 0.14
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 6.28
PEG Ratio: 8.83
Return on Equity: 10.62%
Return on Assets: 2.33%
Gross Margin: 81.76%
Operating Margin: 3.25%
Profit Margin: 6.49%
Current Ratio: 1.83
Debt/Equity: 0.13
Total Debt: $2.04M
Free Cash Flow: $3.98M
Revenue Growth: 14.40%
Earnings Growth: 652.60%
Enterprise Value: $78.95M

JYNT Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$101.25M	$46.98M	$52.16M	$54.90M
Cost of Revenue	$9.17M	$10.48M	$11.52M	$11.23M
Gross Profit	$92.08M	$36.50M	$40.65M	$43.67M
Selling, General & Admin	$84.20M	$34.92M	$41.10M	$42.93M
Operating Expenses	$90.84M	$36.20M	$42.47M	$44.58M
Operating Income	$1.24M	$297.40K	-$1.82M	-$905.48K
EBITDA	$7.89M	$8.88M	$2.90M	$808.24K
Pretax Income	$695.15K	$254.01K	-$1.61M	-$229.50K
Income Tax	$68.45K	$11.02M	$5.61K	$38.65K
Net Income	$626.71K	-$9.75M	-$5.80M	$2.91M
Diluted EPS	0.08	-0.66	-0.57	0.19
Diluted Shares	14.87M	14.94M	15.15M	15.13M

JYNT Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$9.75M	$18.15M	$25.05M	$23.60M
Receivables	$3.91M	$2.58M	$2.59M	$2.85M
Current Assets	$17.61M	$44.34M	$74.58M	$52.09M
Total Assets	$93.49M	$87.21M	$83.15M	$60.97M
Current Liabilities	$23.22M	$33.57M	$49.04M	$32.82M
Long-Term Debt	$2.00M	$2.00M	—	—
Total Debt	$26.06M	$2.86M	$795.03K	$2.01M
Total Liabilities	$60.90M	$62.44M	$62.48M	$45.89M
Retained Earnings	-$12.15M	-$21.91M	-$27.70M	-$24.80M
Shareholders' Equity	$32.56M	$24.75M	$20.65M	$15.05M
Working Capital	-$5.60M	$10.76M	$25.54M	$19.27M

JYNT Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$8.21M	$14.68M	$9.42M	$1.84M
Capital Expenditure	-$5.90M	-$5.00M	-$1.19M	-$1.50M
Free Cash Flow	$2.31M	$9.68M	$8.23M	$334.72K
Depreciation & Amortisation	$6.65M	$8.58M	$4.72M	$1.71M
Stock-Based Compensation	$1.27M	$1.74M	$1.68M	$1.30M
Investing Cash Flow	-$17.90M	-$6.19M	-$631.55K	$6.27M
Financing Cash Flow	$328.61K	$174.12K	-$2.00M	-$9.81M
Share Repurchases	—	—	$0.00	-$11.31M
Net Change in Cash	-$9.36M	$8.66M	$6.78M	-$1.69M

JYNT Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$13.08M	$13.27M	$13.38M	$15.17M	$14.82M	$15.18M
Cost of Revenue	$2.97M	$2.77M	$2.66M	$2.82M	$2.72M	$2.48M
Gross Profit	$10.11M	$10.50M	$10.72M	$12.35M	$12.10M	$12.70M
Selling, General & Admin	$10.42M	$11.23M	$10.11M	$11.17M	$10.80M	$12.44M
Operating Expenses	$10.78M	$11.63M	$10.56M	$11.60M	$11.20M	$12.87M
Operating Income	-$676.56K	-$1.13M	$160.91K	$743.89K	$899.00K	-$160.56K
EBITDA	-$288.25K	-$714.31K	$623.96K	$1.19M	$1.30M	$263.99K
Pretax Income	-$492.62K	-$978.25K	$300.72K	$940.64K	$1.11M	-$242.22K
Income Tax	$13.40K	$11.39K	$10.35K	$3.51K	$11.11K	$9.11K
Net Income	$967.80K	$93.36K	$855.01K	$991.10K	$1.30M	$653.02K
Diluted EPS	0.05	0.01	0.06	0.07	0.09	0.05
Diluted Shares	15.26M	15.40M	15.40M	14.58M	14.19M	14.25M

JYNT Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$21.92M	$29.81M	$29.70M	$23.60M	$20.68M	$22.16M
Receivables	$2.97M	$2.79M	$2.90M	$2.85M	$2.34M	$2.41M
Current Assets	$67.83M	$63.75M	$60.50M	$52.09M	$49.59M	$43.80M
Total Assets	$77.19M	$73.18M	$69.39M	$60.97M	$57.92M	$51.63M
Current Liabilities	$42.71M	$35.51M	$33.05M	$32.82M	$30.17M	$23.98M
Total Debt	$2.25M	$2.17M	$2.09M	$2.01M	$2.04M	$2.04M
Total Liabilities	$57.26M	$49.92M	$46.66M	$45.89M	$42.43M	$35.75M
Retained Earnings	-$29.63M	-$26.64M	-$25.79M	-$24.80M	-$23.50M	-$22.84M
Shareholders' Equity	$19.91M	$23.24M	$22.70M	$15.05M	$15.47M	$15.85M
Working Capital	$25.12M	$28.24M	$27.45M	$19.27M	$19.42M	$19.82M

JYNT Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$3.70M	$868.65K	$1.77M	$2.90M	-$1.48M	$2.19M
Capital Expenditure	-$331.50K	-$505.04K	-$317.84K	-$349.40K	-$234.60K	-$256.26K
Free Cash Flow	-$4.03M	$363.61K	$1.46M	$2.55M	-$1.71M	$1.94M
Depreciation & Amortisation	$388.32K	$419.41K	$463.05K	$442.94K	$404.45K	$424.55K
Stock-Based Compensation	$293.94K	$330.99K	$346.21K	$326.30K	$280.00K	$423.18K
Investing Cash Flow	-$291.40K	$7.23M	-$317.84K	-$349.40K	-$234.60K	$904.03K
Financing Cash Flow	$893.18K	$0.00	-$1.74M	-$8.96M	-$1.16M	-$695.26K
Share Repurchases	$0.00	$0.00	-$2.29M	-$9.02M	-$1.15M	-$676.81K
Net Change in Cash	-$3.10M	$8.10M	-$286.22K	-$6.41M	-$2.88M	$2.40M

Market Snapshot

About

The Joint Corp. operates and franchises chiropractic clinics throughout the United States. The company provides affordable, convenient, and accessible chiropractic care through a membership-based model that eliminates the need for insurance or appointments. The Joint operates both company-owned and franchised clinics in retail locations such as shopping centers and strip malls. The company has pioneered a consumer-friendly approach to chiropractic care with transparent pricing and walk-in convenience.